Antibiotics (Sep 2022)

Novel Megaplasmid Driving NDM-1-Mediated Carbapenem Resistance in <i>Klebsiella pneumoniae</i> ST1588 in South America

  • Mario Quezada-Aguiluz,
  • Andrés Opazo-Capurro,
  • Nilton Lincopan,
  • Fernanda Esposito,
  • Bruna Fuga,
  • Sergio Mella-Montecino,
  • Gisela Riedel,
  • Celia A. Lima,
  • Helia Bello-Toledo,
  • Marcela Cifuentes,
  • Francisco Silva-Ojeda,
  • Boris Barrera,
  • Juan C. Hormazábal,
  • Gerardo González-Rocha

DOI
https://doi.org/10.3390/antibiotics11091207
Journal volume & issue
Vol. 11, no. 9
p. 1207

Abstract

Read online

Carbapenem-resistant Enterobacterales (CRE) is a critical public health problem in South America, where the prevalence of NDM metallo-betalactamases has increased substantially in recent years. In this study, we used whole genome sequencing to characterize a multidrug-resistant (MDR) Klebsiella pneumoniae (UCO-361 strain) clinical isolate from a teaching hospital in Chile. Using long-read (Nanopore) and short-read (Illumina) sequence data, we identified a novel un-typeable megaplasmid (314,976 kb, pNDM-1_UCO-361) carrying the blaNDM-1 carbapenem resistance gene within a Tn3000 transposon. Strikingly, conjugal transfer of pNDM-1_UCO-361 plasmid only occurs at low temperatures with a high frequency of 4.3 × 10−6 transconjugants/receptors at 27 °C. UCO-361 belonged to the ST1588 clone, previously identified in Latin America, and harbored aminoglycoside, extended-spectrum β-lactamases (ESBLs), carbapenem, and quinolone-resistance determinants. These findings suggest that blaNDM-1-bearing megaplasmids can be adapted to carriage by some K. pneumoniae lineages, whereas its conjugation at low temperatures could contribute to rapid dissemination at the human–environmental interface.

Keywords